EDESA BIOTECH, INC. Payments of Derivative Issuance Costs
EDESA BIOTECH, INC. (EDSA) reported Payments of Derivative Issuance Costs of $0 for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfDerivativeIssuanceCosts · last filed 2026-08-13
- EDESA BIOTECH, INC. payments of derivative issuance costs for the quarter ending 2026-06-30 was $0.00.
- EDESA BIOTECH, INC. payments of derivative issuance costs for the quarter ending 2025-09-30 was $0.00.
- EDESA BIOTECH, INC. payments of derivative issuance costs for the quarter ending 2025-06-30 was $0.00.
- EDESA BIOTECH, INC. payments of derivative issuance costs for the quarter ending 2024-09-30 was $0.00.
- EDESA BIOTECH, INC. payments of derivative issuance costs for fiscal 2025 was $23.45K.
- EDESA BIOTECH, INC. payments of derivative issuance costs for fiscal 2024 was $0.00.
| Period end | Payments of Derivative Issuance Costs 3 month | Payments of Derivative Issuance Costs 6 month | Payments of Derivative Issuance Costs 9 month | Payments of Derivative Issuance Costs 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-13 | $0.00 10-Q · filed 2026-08-13 | ||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-14 | |||
| 2025-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-12 | $0.00 derived: sum of 2 quarters · filed 2026-08-13 | $23.45K 10-K · filed 2025-12-12 | |
| 2025-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-13 | $23.45K 10-Q · filed 2026-08-13 | ||
| 2025-03-31 | $23.45K 10-Q · filed 2026-05-14 | |||
| 2024-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-12 | $0.00 derived: sum of 2 quarters · filed 2025-12-12 | $0.00 10-K · filed 2025-12-12 | |
| 2024-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-08 | $0.00 10-Q · filed 2025-08-08 | ||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |